Trial Profile
A prospective open label add on treatment study of rufinamide in children with refractory epilepsy symptomatic of neuronal migration disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Rufinamide (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 04 Dec 2015 New trial record